Cardiovascular Systems (NSDQ:CSII) posted third-quarter results yesterday that beat the revenue consensus on Wall Street but missed on earnings projections. The St. Paul, Minn.-based company reported losses of -$6 million, or -15¢ per share, on sales of $63.27 million for the three months ended March 31, for a sales growth of 3.43% compared with Q1 […]
Featured
iRhythm Technologies ticks up before hours on mixed-bag Q1 results
iRhythm Technologies (NASDAQ: IRTC) posted first-quarter results yesterday that missed the earnings consensus on Wall Street but beat the revenue projections. The San Francisco-based company reported losses of -$27.8 million, or -95¢ per share, on sales of $74.3 million for the three months ended March 31, for a sales growth of 16.96% compared with Q1 2020. […]
Alphatec sales up 46% in Q1 results
Alphatec (Nasdaq: ATEC) posted first-quarter results yesterday that missed the earnings consensus on Wall Street and matched on revenue estimates. The Carlsbad, Calif.-based company reported losses of -$22.9 million, or -26¢ per share, on sales of $44.12 million for the three months ended March 31, for a sales growth of 46.51% compared with Q1 2020. Earnings […]
Zimmer Biomet is looking to put sensors in more than just knee implants
Even as Zimmer Biomet prepares to launch its Persona-IQ smart knee implant later this year, the ortho device giant is looking at additional opportunities to package sensors inside ortho implants. Startup Canary Medical (Vancouver, British Columbia), which created the Canary Health Implantable Reporting Processor (CHIRP) that is going inside the Persona-IQ, has cemented a long-term […]
Cardinal Health stock down 8% on Q3 earnings miss
Cardinal Health (NYSE:CAH) stock is down today after the company’s third-quarter earnings missed the Wall Street consensus forecast. The Dublin, Ohio–based medical device manufacturer and life science products distributor reported profits of $119 million, or 40¢ per share, off sales of $39.275 billion for the quarter ended March 31, 2021, with earnings down two-thirds off […]
BD to spin off its diabetes business, Q2 earnings beat The Street
BD (NYSE: BDX) announced today that it will spin off its Diabetes Care business as an independent, publicly traded company during the first half of 2022. The Diabetes Care business saw $1.1 billion in sales during BD’s fiscal year ended Sept. 30, 2020, nearly half outside the U.S. The business manufactures roughly 8 billion injection […]
Lilly partners with four companies on insulin pen tech
Eli Lilly (NYSE:LLY) today announced deals with four companies whose diabetes management tech will work with Lilly’s latest insulin pen. The Tempo Pen is a modified version of Lilly’s existing prefilled, disposable insulin pen to which the Tempo Smart Button — in late-stage development – attaches. Through these new agreements, the Tempo Smart Button will […]
Tandem Diabetes Care beats The Street in Q1, raises guidance
Tandem Diabetes Care (NSDQ:TNDM) narrowed its losses year-over-year in Q1, with results beating the consensus forecast on Wall Street. The San Diego-based company yesterday evening posted losses of –$5 million, or –8¢ per share, on sales of $141 million for the three months ended March 31, 2021, reducing losses by nearly two-thirds on sales growth […]
Cutera stock up on reported Q1 sales growth
Cutera (NSDQ:CUTR) posted first-quarter results that beat the overall consensus on Wall Street. The Brisbane, Calif.–based cosmetic and aesthetic laser equipment company yesterday reported losses of -$359,000, or -2¢ per share, on sales of $49.668 million for the three months ended March 31, for a sales growth of 54.06% compared with Q1 2020. Earnings per […]
Conformis slides on mixed-bag Q1 results
Conformis (NSDQ:CFMS) posted first-quarter results that beat the revenue consensus on Wall Street but missed on earnings. The Billerica, Mass.-based orthopedic company yesterday reported losses of -$11.51 million, or -9¢ per share, on sales of $13.84 million for the three months ended March 31, for a sales loss of -16.02% compared with Q1 2020. Earnings […]
Outset Medical sales more than triple in Q1
Outset Medical (NSDQ:OM) posted first-quarter results that beat the overall consensus on Wall Street and increased its guidance. The San Jose, Calif.-based Tablo dialysis machine maker reported losses of -$30 million, or -70¢ per share, on sales of $22.9 million for the three months ended March 31, for a sales growth of 218.72% compared with […]
